| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/11/2001 | WO2001074814A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 10/11/2001 | WO2001074807A1 Indolylpyrrole derivatives and cell death inhibitors |
| 10/11/2001 | WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074797A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands |
| 10/11/2001 | WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 10/11/2001 | WO2001074790A2 Novel compounds for enhancing chemotherapy |
| 10/11/2001 | WO2001074787A2 Crystalline pharmaceutical |
| 10/11/2001 | WO2001074784A1 CYCLIC LACTAMS AS INHIBITORS OF A-β PROTEIN PRODUCTION |
| 10/11/2001 | WO2001074783A1 Cyclic lactams as inhibitors of a βετα protein production |
| 10/11/2001 | WO2001074779A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 10/11/2001 | WO2001074772A1 Chemokine receptor antagonists |
| 10/11/2001 | WO2001074763A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof |
| 10/11/2001 | WO2001074404A2 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor |
| 10/11/2001 | WO2001074394A1 New combination of a betablocker and a cholesterol-lowering agent |
| 10/11/2001 | WO2001074389A2 Improved treatment of neovascularization |
| 10/11/2001 | WO2001074382A1 Method of treatment using ligand-immunogen conjugates |
| 10/11/2001 | WO2001074366A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/11/2001 | WO2001074365A2 An efficacious dosage regimen of galantamine that reduces side effects |
| 10/11/2001 | WO2001074362A1 Inhibition of cyclooxygenase-2 activity |
| 10/11/2001 | WO2001074360A1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 10/11/2001 | WO2001074359A1 Sigma receptor ligands and their medical uses |
| 10/11/2001 | WO2001074356A1 Concentrated solutions of carvedilol |
| 10/11/2001 | WO2001074355A1 Method for treating cells resistant to antineoplastic agents |
| 10/11/2001 | WO2001074349A1 Butylnitrone containing compositons for inhibition of cancer development |
| 10/11/2001 | WO2001074348A2 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 10/11/2001 | WO2001074344A2 Small organic molecule regulators of cell proliferation |
| 10/11/2001 | WO2001074333A1 D and l etherlipid stereoisomers and liposomes |
| 10/11/2001 | WO2001074317A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001074313A2 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins |
| 10/11/2001 | WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 10/11/2001 | WO2001074296A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 10/11/2001 | WO2001074295A2 Phospholipid scramblases and methods of use thereof |
| 10/11/2001 | WO2001074164A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001074136A2 Telomerase inhibitor polynucleotides |
| 10/11/2001 | WO2001066139A8 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| 10/11/2001 | WO2001045746A3 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 10/11/2001 | WO2001036640A3 Human fgf-21 gene and gene expression products |
| 10/11/2001 | WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors |
| 10/11/2001 | WO2001027119A3 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 10/11/2001 | WO2001025269A3 Human g-protein coupled receptor |
| 10/11/2001 | WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 10/11/2001 | WO2001022951A3 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 10/11/2001 | WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 10/11/2001 | WO2001019826A3 Triazolopyrimidine derivatives |
| 10/11/2001 | WO2001012264A3 Topical azathioprine for the treatment of oral autoimmune diseases |
| 10/11/2001 | WO2001002377A9 Telomerase inhibitors and methods of their use |
| 10/11/2001 | WO2000076556A3 High dose radionuclide complexes for bone marrow suppression |
| 10/11/2001 | WO2000042429A3 In vitro model for gastrointestinal inflammation |
| 10/11/2001 | WO2000041472A3 Binding partners for 5-ht5-receptors for the treatment of migraine |
| 10/11/2001 | WO2000017176A3 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 10/11/2001 | US20010029265 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 10/11/2001 | US20010029253 Composition for external application containing a beta-1,6-branched-beta-1,3-glucan |
| 10/11/2001 | US20010029250 Antiinflammatory agents; anticarcinogenic agents |
| 10/11/2001 | US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase |
| 10/11/2001 | US20010029246 Antiproliferative agent |
| 10/11/2001 | US20010029040 Agent for gene therapy of dilated cardomyopathy |
| 10/11/2001 | US20010028899 Composition for supprssing cellular fibrousing and method for preparing an extract from loquat seeds |
| 10/11/2001 | US20010028893 Pressurization |
| 10/11/2001 | US20010028889 Topical |
| 10/11/2001 | US20010028879 Inhibition of graft versus host disease |
| 10/11/2001 | EP1145001A3 (in vitro) model for gastrointestinal inflammation |
| 10/11/2001 | DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate |
| 10/11/2001 | DE10015814A1 Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung Medicines to stimulate leukopoiesis, for the treatment of tumors and protozoal diseases and process for its preparation |
| 10/11/2001 | DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate |
| 10/11/2001 | CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 10/11/2001 | CA2405496A1 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 10/11/2001 | CA2405299A1 Method of treatment using ligand-immunogen conjugates |
| 10/11/2001 | CA2404965A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/11/2001 | CA2404890A1 Rna sequence-specific mediators of rna interference |
| 10/11/2001 | CA2404665A1 Novel compounds for enhancing chemotherapy |
| 10/11/2001 | CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 10/11/2001 | CA2404572A1 Inhibition of thrombosis by treatment with p-selectin antagnosits |
| 10/11/2001 | CA2404545A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same |
| 10/11/2001 | CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 10/11/2001 | CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 10/11/2001 | CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 10/11/2001 | CA2404475A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands |
| 10/11/2001 | CA2404413A1 Small organic molecule regulators of cell proliferation |
| 10/11/2001 | CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production |
| 10/11/2001 | CA2404312A1 Chemokine receptor antagonists |
| 10/11/2001 | CA2404291A1 Butylnitrone containing compositons for inhibition of cancer development |
| 10/11/2001 | CA2404040A1 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 10/11/2001 | CA2404023A1 Cyclic lactams as inhibitors of a.beta. protein production |
| 10/11/2001 | CA2403991A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | CA2403635A1 Crystalline hydrated lopinavir |
| 10/11/2001 | CA2403612A1 Improved treatment of neovascularization |
| 10/11/2001 | CA2403608A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/11/2001 | CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | CA2403550A1 Cyclic lactams as inhibitors of a-.beta. protein production |
| 10/11/2001 | CA2403160A1 New combination of a betablocker and a cholesterol-lowering agent |
| 10/11/2001 | CA2402864A1 D and l etherlipid stereoisomers and liposomes |
| 10/11/2001 | CA2402416A1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 10/11/2001 | CA2401854A1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 10/11/2001 | CA2401104A1 Method for treating cells resistant to antineoplastic agents |
| 10/11/2001 | CA2400057A1 4-oxo-1,4-dihydro¬1,8|naphthyridine-3-carboxamides as antiviral agents |
| 10/11/2001 | CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | CA2397203A1 Phosphoramidate prodrugs |